LumineticsCore is the first ever FDA-approved autonomous AI system for detecting diabetic retinopathy and macular edema. The technology improves access to eye exams and follow-up care for people living with diabetes.


LumineticsCore is the first ever FDA-approved autonomous AI system for detecting diabetic retinopathy and macular edema. The technology improves access to eye exams and follow-up care for people living with diabetes.
[logoshowcase animation=”fadeIn” show_title=”false” rows=”2″ dots=”false” autoplay_interval=”5000″ center_mode=”true” orderby=”title” order=”asc” cat_id=”31″ exclude_post=”5427″]

OCHIN, Inc.
PO Box 5426
Portland, OR 97228-5426
(503) 943-2500
OCHIN Connections is a monthly newsletter featuring the latest news and impact from the OCHIN network, supporting our vision of health and well-being for all.